Physician perceptions and experience of current treatment in actinic keratosis

Journal of the European Academy of Dermatology and Venereology

Volumn 29, Issue 2, 2015, Pages 298-306

  Stockfleth, E ^a   Peris, K ^b   Guillen, C ^c   Cerio, R ^d   Basset Seguin, N ^e   Foley, P ^f   Sanches, J ^g   Culshaw, A ^h   Erntoft, S ⁱ   Lebwohl, M ^j  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b CATHOLIC UNIVERSITY   (Italy)

^c INSTITUTO VALENCIANO DE ONCOLOGÍA   (Spain)

^d BARTS HEALTH NHS TRUST   (United Kingdom)

^e SAINT LOUIS HOSPITAL   (France)

^f UNIVERSITY OF MELBOURNE   (Australia)

^g UNIVERSITY OF SÃO PAULO   (Brazil)

^h ADELPHI REAL WORLD   (United Kingdom)

ⁱ LEO PHARMA A S   (Denmark)

^j MOUNT SINAI HOSPITAL   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

DICLOFENAC; FLUOROURACIL; IMIQUIMOD; INGENOL MEBUTATE;

ACTINIC KERATOSIS; ARTICLE; CRYOTHERAPY; HUMAN; LOW LEVEL LASER THERAPY; MAJOR CLINICAL STUDY; MEDICAL PRACTICE; MEDICATION COMPLIANCE; PHOTODYNAMIC THERAPY; PHYSICIAN ATTITUDE; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUESTIONNAIRE; SKIN ABRASION; TOPICAL TREATMENT; HEALTH PERSONNEL ATTITUDE; KERATOSIS, ACTINIC; PHYSICIAN; PSYCHOLOGY;

ATTITUDE OF HEALTH PERSONNEL; HUMANS; KERATOSIS, ACTINIC; PHYSICIANS; QUESTIONNAIRES;

EID: 84921564390     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/jdv.12530     Document Type: Article

References (29)

1. Peris K, Micantonio T, Piccolo D, Fargnoli MC,. Dermoscopic features of actinic keratosis. J Dtsch Dermatol Ges 2007; 5: 970-976.
2. Traianou A, Ulrich M, Apalla Z, et al,. Risk factors for actinic keratosis in eight European centres: a case-control study. Br J Dermatol 2012; 167 (Suppl 2): 36-42.
3. Fartasch M, Diepgen TL, Schmitt J, Drexler H,. The relationship between occupational sun exposure and non-melanoma skin cancer: clinical basics, epidemiology, occupational disease evaluation, and prevention. Dtsch Arztebl Int 2012; 109: 715-720.
4. Frost CA, Green AC, Williams GM,. The prevalence and determinants of solar keratoses at a subtropical latitude (Queensland, Australia). Br J Dermatol 1998; 139: 1033-1039.
5. Rosen T, Lebwohl MG,. Prevalence and awareness of actinic keratosis: barriers and opportunities. J Am Acad Dermatol 2013; 68 (1 Suppl 1): S2-S9.
6. Stockfleth E, Terhorst D, Braathen L, et al,. Guideline on Actinic Keratoses (2010). European Dermatology Forum. Available on www.euroderm.org, retrieved on 16.04.2013.
7. Araki K, Nagano T, Ueda M, et al,. Incidence of skin cancers and precancerous lesions in Japanese-risk factors and prevention. J Epidemiol 1999; 9 (6 Suppl): S14-S21.
8. Memon AA, Tomenson JA, Bothwell J, Friedmann PS,. Prevalence of solar damage and actinic keratosis in a Merseyside population. Br J Dermatol 2000; 142: 1154-1159.
9. Lucas RM, McMichael AJ, Armstrong BK, Smith WT,. Estimating the global disease burden due to ultraviolet radiation exposure. Int J Epidemiol 2008; 37: 654-667.
10. Green A,. Changing patterns in incidence of non-melanoma skin cancer. Epithelial Cell Biol 1992; 1: 47-51.
11. Lansbury L, Leonardi-Bee J, Perkins W, et al,. Interventions for non-metastatic squamous cell carcinoma of the skin. Cochrane Database Syst Rev 2010; 14: CD007869.
12. Czarnecki D, Meehan CJ, Bruce F, et al,. The majority of cutaneous squamous cell carcinomas arise in actinic keratoses. J Cutan Med Surg 2002; 6: 207-209.
13. Ackerman AB,. Solar keratosis is squamous cell carcinoma. Arch Dermatol 2003; 139: 1216-1217.
14. Heaphy MR Jr, Ackerman AB,. The nature of solar keratosis: a critical review in historical perspective. J Am Acad Dermatol 2000; 43 (1 Pt 1): 138-150.
15. Giles GG, Marks R, Foley P,. Incidence of non-melanocytic skin cancer treated in Australia. Br Med J (Clin Res Ed) 1988; 296: 13-17.
16. Marks R, Rennie G, Selwood TS,. Malignant transformation of solar keratoses to squamous cell carcinoma. Lancet 1988; 1: 795-797.
17. Mittelbronn MA, Mullins DL, Ramos-Caro FA, et al,. Frequency of pre-existing actinic keratosis in cutaneous squamous cell carcinoma. Int J Dermatol 1998; 37: 677-681.
18. Dinehart SM, Nelson-Adesokan P, Cockerell C, et al,. Metastatic cutaneous squamous cell carcinoma derived from actinic keratosis. Cancer 1997; 79: 920-923.
19. Feldman SR, Fleischer AB,. Progression of Actinic Keratosis to Squamous Cell Carcinoma Revisited: clinical and Treatment Implications. Cutis 2013; 87: 201-207.
20. Cohen JL,. Actinic keratosis treatment as a key component of preventive strategies for nonmelanoma skin cancer. J Clin Aesthet Dermatol 2010; 3: 39-44.
21. Neidecker MV, Davis-Ajami ML, Balkrishnan R, et al,. Pharmacoeconomic considerations in treating actinic keratosis. Pharmacoeconomics 2009; 27: 451-464.
22. Stockfleth E, Ferrandiz C, Grob JJ, et al,. Development of a treatment algorithm for actinic keratoses: a European Consensus. Eur J Dermatol 2008; 18: 651-659.
23. McIntyre WJ, Downs MR, Bedwell SA,. Treatment options for actinic keratoses. Am Fam Physician 2007; 76: 667-671.
24. Lebwohl M, Swanson N, Anderson LL, et al,. Ingenol mebutate gel for actinic keratosis. N Engl J Med 2012; 366: 1010-1019.
25. Puig L, Ribera M, Hernanz JM, et al,. Treatment of scalp psoriasis: review of the evidence and Delphi consensus of the Psoriasis Group of the Spanish Academy of Dermatology and Venereology. Actas Dermosifiliogr 2010; 101: 827-846.
26. Pope E, Lara-Corrales I, Mellerio J, et al,. A consensus approach to wound care in epidermolysis bullosa. J Am Acad Dermatol 2012; 67: 904-917.
27. Shoimer I, Rosen N, Muhn C,. Current management of actinic keratoses. Skin Therapy Lett 2010; 15: 5-7.
28. Berker D, McGregor J,. Guidelines for the management of actinic keratosis. Br J Dermatol 2006; 156: 222-230.
29. Tierney EP, Eide MJ, Jacobsen G, et al,. Photodynamic therapy for actinic keratoses: survey of patient perceptions of treatment satisfaction and outcomes. J Cosmet Laser Ther 2008; 10: 81-86.